Clinical Report: Lupus Disease Activity Linked to Incontinence
Overview
A significant proportion of adults with systemic lupus erythematosus (SLE) experience urinary incontinence (UI), with higher disease activity correlating with increased odds of UI. This study highlights the need for routine screening and management of UI in SLE patients.
Background
Urinary incontinence is often underreported in patients with systemic lupus erythematosus, despite its prevalence and potential impact on quality of life. Understanding the relationship between disease activity and UI is crucial for comprehensive patient care. This study sheds light on the association between higher disease activity and increased UI incidence, emphasizing the importance of addressing this issue in clinical practice.
Data Highlights
| Measure | Percentage |
|---|---|
| Reported UI (at least monthly) | 36.2% |
| Mixed-type UI | 57.8% |
| Moderate symptom severity | 25.0% |
| Severe or very severe UI | 8.7% |
| UI described as bothersome | 39.0% |
Key Findings
- 36.2% of adults with SLE reported urinary incontinence occurring at least monthly.
- Higher disease activity was associated with nearly threefold increased odds of UI.
- Mixed-type UI was the most common subtype, affecting 57.8% of those with UI.
- 39.0% of participants with UI found it to be very or greatly bothersome.
- Neuropsychiatric damage was linked to more than twofold higher odds of UI.
Clinical Implications
Healthcare providers should routinely screen for urinary incontinence in patients with systemic lupus erythematosus, particularly those with higher disease activity. Addressing UI can significantly improve patients' quality of life and daily functioning.
Conclusion
The findings underscore the importance of recognizing and managing urinary incontinence as a relevant aspect of systemic lupus erythematosus care, particularly in patients experiencing active disease states.
References
- Urinary Incontinence Among Adults With Systemic Lupus Erythematosus - PubMed, ACR Open Rheumatology, 2025 -- Urinary Incontinence Among Adults With Systemic Lupus Erythematosus
- Factors Influencing Disease Activity Improvement in Initially Hospitalized Systemic Lupus Erythematosus Patients: A Retrospective Multicenter Study of a Chinese Population, Clinical Rheumatology, 2022 -- Factors Influencing Disease Activity Improvement
- Clinical and Serological Links of Urinary Activated Leukocyte Cell Adhesion Molecule in Systemic Lupus Erythematosus and Associated Lupus Nephritis, Clinical Rheumatology, 2024 -- Clinical and Serological Links
- Initial Disease Activity as a Prognostic Indicator for Outcomes in Systemic Lupus Erythematosus Patients: Insights from a Retrospective Analysis of the COMOSLE-EGYPT Study, Clinical Rheumatology, 2024 -- Initial Disease Activity as a Prognostic Indicator
- Assessment of Urinary Neutrophil Gelatinase-Associated Lipocalin (uNGAL) and Kidney Injury Molecule-1 (uKIM-1) as Indicators of Active Lupus Nephritis, Clinical Rheumatology, 2023 -- Assessment of Urinary Neutrophil Gelatinase-Associated Lipocalin
- Urinary Incontinence Among Adults With Systemic Lupus Erythematosus - PubMed
- https://rheumatology.org/api/asset/bltec93920aad624e33
This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.
